Results 111 to 120 of about 1,414,634 (195)
Scleroderma sine scleroderma (ssSSc) is an occult form of systemic sclerosis that may cause diagnostic difficulties due to the absence of skin involvement.
Tzelepis, G.E., Toya, S.P.
core +1 more source
Walsh & Hoyt: Scleroderma (Systemic Sclerosis)
Scleroderma (from the Greek words, skleros, meaning ""hard,"" and derma, meaning ""skin"") is a generalized disorder of connective tissue. This condition, also called ""systemic sclerosis,"" is characterized by fibrous and degenerative changes in the ...
Steven L. Galetta, MD
core
Vascular involvement in systemic sclerosis (scleroderma)
Debendra Pattanaik1, Monica Brown2, Arnold E Postlethwaite11Division of Connective Tissue Diseases, Department of Medicine; 2Section of Pediatric Rheumatology Department of Pediatrics, University of Tennessee Health Science Center, and Department of ...
Brown M, Pattanaik D, Postlethwaite AE
core
T‐cell engagers in autoimmune rheumatic diseases: From concept to clinical practice
Clinical and Translational Medicine, Volume 16, Issue 11, November 2026.
Christina Düsing +2 more
wiley +1 more source
This dataset contains supplementary figures and tables for the accepted manuscript in JAAD, titled “Pruritic papules in systemic sclerosis is associated with scleroderma renal ...
huang, junxia
core +1 more source
A Case Report on a Challenge From Diagnosis to Treatment: Interstitial Lung Disease As the First Manifestation of Systemic Sclerosis Sine Scleroderma. [PDF]
Viana S +4 more
europepmc +1 more source
Refractory Digital Ulcers in Systemic Sclerosis Sine Scleroderma Associated With Antiphospholipid Syndrome: A Case-Based Review. [PDF]
Almeida I +5 more
europepmc +1 more source
Ischemic Necrosis of Bilateral Second Toes in the Absence of Macrovascular Disease or Primary Vasculitis: A Unique Case of Systemic Sclerosis Sine Scleroderma (ssSSc). [PDF]
Elhaddad M +4 more
europepmc +1 more source
Background: Interstitial lung disease is the leading cause of morbidity and mortality in systemic sclerosis, but it is characterized by significant heterogeneity in patient outcomes. So far, little is known about the influence of anti-U1RNP antibodies on
Launay, David +8 more
core +1 more source

